Women had been menopausal for 5-7 years, and had never been treated with hormone replacement or drug therapy. Regression analysis was performed to correlate BMC and intake levels. Calcium and magnesium intakes were lower than the recommended daily allowance even in normal women. The results suggest that nutritional factors are relevant to bone health in postmenopausal women, and dietary supplementation may be indicated for the prophylaxis of osteoporosis. Adequate nutritional recommendations and supplements should be given before the menopause, and dietary evaluation should be mandatory in treating postmenopausal osteoporosis.
Osteoporosis is a disease that characteristically afflicts postmenopausal women.
It is estimated that millions of people are plagued yearly with this debilitating disease. Associated health care costs are in the billions of dollars, annually. Much research has been conducted in the area of osteoporosis and mineral supplementation, mainly focusing on calcium and vitamin D. Nonetheless, more recent studies have reported possible improvements in bone mineral density in women who were supplemented with the ultra-trace mineral, boron. Although the focus of this review will be to discuss the interactive role of boron with magnesium and bone metabolism, some discussion of its interactive role with vitamin D is also necessary. 291-6 Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome.